FIDVAXI
Genexine, Inc.
Application Filed: 2022-09-01
Trademark Application Details
NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
| Research |
OneLook
Acronym Finder
|
| Serial Number | 79352877 |
| Mark Drawing Code | 5000: Illustration: Drawing with word(s)/letter(s)/number(s) in Stylized form |
Timeline
| 2022-09-01 | Application Filed |
| 2022-10-20 | Location: INITIAL REVIEW/SERIALIZATION BRANCH(MAILROOM) |
| 2022-10-20 | Status: Live/Pending |
| 2022-10-21 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  Genexine, Inc. |
| Address | (Magokdong, Bio Innovation Park) 172, Magokjungang-ro, Gangseo-gu Seoul KR |
| Legal Entity Type | Corporation |
| Legal Entity State | KR |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 5 |
| U.S. Codes: | 005,006,018,044,046,051,052 |
| Type Code | Type |
|---|---|
| GS0051 | Pharmaceutical products for the treatment of infectious diseases; immunomodulators; viral vaccines; pharmaceutical preparations for the treatment of viral diseases; vaccines; vaccine preparations; pharmaceutical preparations and substances for use in gynecology; pharmaceutical preparations and compositions for the treatment and prevention of cancer; pharmaceutical preparations and substances for the prevention of cancer; pharmaceutical products for the treatment of viral and infectious diseases of cancer patients; biopharmaceuticals for the treatment of cancer; biological preparations for the treatment of cancer; pharmaceutical preparations for the treatment of cancer; pharmaceuticals; human vaccine preparations; medicines for human purposes; pharmaceutical preparations for the treatment of tumours; pharmaceutical preparations for suppressing tumors; therapeutic drugs and agents; anti-cancer preparations |
| GS0051 | Pharmaceutical products for the treatment of infectious diseases; Pharmaceutical preparations for the treatment of immune system related diseases and disorders, namely, immunomodulators; viral vaccines; pharmaceutical preparations for the treatment of viral diseases; vaccines; vaccine preparations; pharmaceutical preparations and substances for use in gynecology; pharmaceutical preparations and compositions for the treatment and prevention of cancer; pharmaceutical preparations and substances for the prevention of cancer; pharmaceutical products for the treatment of viral and infectious diseases of cancer patients; biopharmaceutical preparations for the treatment of cancer; biological preparations for the treatment of cancer; pharmaceutical preparations for the treatment of cancer; human vaccine preparations; pharmaceutical preparations for the treatment of tumors; pharmaceutical preparations for suppressing tumors |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| SN ASSIGNED FOR SECT 66A APPL FROM IB | 2022-10-20 | 1 REPR M: |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2022-10-21 | 2 NWOS I:Incoming Correspondence |
| APPLICATION FILING RECEIPT MAILED | 2022-10-25 | 3 MAFR O:Outgoing Correspondence |
| ASSIGNED TO EXAMINER | 2022-11-02 | 4 DOCK D:Assigned to Examiner |
| NON-FINAL ACTION WRITTEN | 2022-11-02 | 5 CNRT R:Renewal |
| NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | 2022-11-03 | 6 RFCR E:E-Mail |
| REFUSAL PROCESSED BY MPU | 2023-01-12 | 7 RFRR P: |
| NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | 2023-01-12 | 8 RFCS P: |
| REFUSAL PROCESSED BY IB | 2023-02-02 | 9 RFNT P: |
| TEAS CHANGE OF OWNER ADDRESS RECEIVED | 2023-06-13 | 10 COAR I:Incoming Correspondence |
| APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | 2023-06-13 | 11 CHAN I:Incoming Correspondence |
| TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2023-06-13 | 12 REAP I:Incoming Correspondence |
| ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2023-06-13 | 13 ARAA I:Incoming Correspondence |
| TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | 2023-06-13 | 14 ECDR I:Incoming Correspondence |
| TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2023-06-13 | 15 TCCA I:Incoming Correspondence |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2023-07-06 | 16 TROA I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2023-07-06 | 17 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2023-07-06 | 18 TEME I:Incoming Correspondence |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2023-08-04 | 19 CNSA O:Outgoing Correspondence |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2023-08-23 | 20 NONP E:E-Mail |
| NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | 2023-08-23 | 21 OP2R P: |
| NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | 2023-08-23 | 22 OPNS P: |
| PUBLISHED FOR OPPOSITION | 2023-09-12 | 23 PUBO A:Allowance for Publication |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2023-09-12 | 24 NPUB E:E-Mail |
| NOTIFICATION PROCESSED BY IB | 2023-09-12 | 25 GPNX P: |
| REGISTERED-PRINCIPAL REGISTER | 2023-11-28 | 26 R.PR A:Allowance for Publication |
| NOTICE OF REGISTRATION CONFIRMATION EMAILED | 2023-11-28 | 27 NRCC E:E-Mail |
| FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | 2024-02-28 | 28 FICR P: |
| FINAL DISPOSITION PROCESSED | 2024-03-04 | 29 FIMP P: |
| FINAL DISPOSITION NOTICE SENT TO IB | 2024-03-04 | 30 FICS P: |
| FINAL DECISION TRANSACTION PROCESSED BY IB | 2024-03-26 | 31 FINO P: |
Similar Marks
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 FIDVAXI 79352877 not registered Live/Pending |
Genexine, Inc. 2022-09-01 |
 FIDVAXI 79352782 not registered Live/Pending |
Genexine, Inc. 2022-09-01 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 